Clinical Utility of Circulating Pentraxin 3 as a Prognostic Biomarker in Coronavirus Disease 2019: A Systematic Review and Meta-analysis.

Yani KeKaihan WuChenglu ShenYuqing ZhuChuchu XuQiushuang LiJie HuShan Liu

Published in: Infectious diseases and therapy (2022)

This study found that PTX3 was differentially expressed between survival and nonsurvival patients with COVID-19, while there was no significant difference between ICU and non-ICU patients. Meanwhile, circulating PTX3 may be a good biomarker for monitoring the prognosis of COVID-19, which may provide new ideas and directions for clinical and scientific research.

Keyphrases

coronavirus disease
end stage renal disease
intensive care unit
newly diagnosed
ejection fraction
sars cov
chronic kidney disease
prognostic factors
respiratory syndrome coronavirus
peritoneal dialysis
acute respiratory distress syndrome